NCT07071246View on ClinicalTrials.gov

Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis

NAActive, not recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

July 31, 2027

Conditions

Treatment

Interventions

DRUG

Rituximab Injection

low dose of rituximab intravenously

Trial Locations (1)

710038

Tangdu Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors

lead

Tang-Du Hospital

OTHER